𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interleukin-1β (IL-1β) and acute leukemia: In vitro proliferative response to IL-1β, IL-1β content of leukemic cells and treatment outcome

✍ Scribed by Kohji Ezaki; Motohiro Tsuzuki; Itsuro Katsuta; Fumio Maruyama; Hiroshi Kojima; Masataka Okamoto; Toshiyuki Nomura; Machiko Wakita; Hitoshi Miyazaki; Ryo Sobue; Toshikazu Matsui; Teruo Ino; Masami Hirano

Book ID
113239831
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
634 KB
Volume
19
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Selective and differential binding of in
Selective and differential binding of interleukin (IL)-1α, IL-1β, IL-2 and IL-6 to glycosaminoglycans
✍ Lawrence Ramsden; Christopher C. Rider 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB

The binding of interleukin (1L)-la, IL-lP, IL-2 and IL-6 to acidic polysaccharides was investigated by affinity chromatography of the recombinant, radioiodinated interleukins on columns of immobilized polysaccharide. Each interleukin showed selective binding retention. Overall heparin bound all four

Interleukin (IL)-1β toxicity to islet β
Interleukin (IL)-1β toxicity to islet β cells: Efaroxan exerts a complete protection
✍ Gianpaolo Papaccio; Antonio Graziano; Salvatore Valiante; Riccardo D'Aquino; Sal 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 371 KB

## Abstract Interleukin (IL)‐1β‐treated rat islets of Langerhans were exposed in vitro either to the imidazoline compound, Efaroxan, or to the selective inducible nitric oxide synthase (iNOS) inhibitor, 1400W, in a medium containing a high concentration of glucose (16.7 mmol/L). Our data have evide